CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $4.24B, above the global median of $1.15B
- PositionGross margin is 92.5%, higher than 95% of its Medical Instruments & Supplies peers (median 54%)
- Interpretations13 currently firing — 1 · 12
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.64%Above 5Y avg (1.33%)
Annual Rate
CNY 1.60Paid semi-annual
Payout Ratio
131.6%High
Payback Period
46.2 yr
Last Ex-Dividend
Apr 29, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
High Dividend Payout With FCF And Equity Ratio
→dividend payout intensity
fcf positive 3y
ratio balance equity
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
High Dividend Payout With FCF And Equity Ratio
It pays out most of its earnings, on three years of positive free cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
28.53BCNY4.24B · vs all stocks (USD)
Trailing P/E
26.18xvs Medical Instruments & Supplies peers
Revenue (TTM)
2.42BCNY359.85M · vs all stocks (USD)
Profit Margin
47.28%vs Medical Instruments & Supplies peers
Beta
0.6160xvs all stocks
52-Week Change
-48.44%vs all stocks
Forward Annual Dividend Yield
1.64%vs all stocks
Market Capitalization
28.53BCNY4.24B · vs all stocks (USD)
Enterprise Value
26.64BCNY3.96B · vs all stocks (USD)
Trailing P/E
26.18xvs Medical Instruments & Supplies peers
Forward P/E
18.82xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
12.43xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.81xvs Medical Instruments & Supplies peers
Enterprise to Revenue
10.99xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
21.57xvs Medical Instruments & Supplies peers
Gross Margin
92.49%vs Medical Instruments & Supplies peers
Profit Margin
47.28%vs Medical Instruments & Supplies peers
Operating Margin
56.48%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
8.36%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
13.75%vs Medical Instruments & Supplies peers
Revenue (TTM)
2.42BCNY359.85M · vs all stocks (USD)
Revenue per Share (TTM)
8.04CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-4.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
2.24BCNY332.11M · vs all stocks (USD)
EBITDA (TTM)
1.42BCNY210.16M · vs all stocks (USD)
Net Income (TTM)
1.15BCNY170.13M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-32.80%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
1.24BCNY184.66M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.11BCNY164.80M · vs all stocks (USD)
Forward Annual Dividend Rate
1.60CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
1.64%vs all stocks
Trailing Annual Dividend Rate
2.00CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
2.05%vs all stocks
5-Year Average Dividend Yield
1.33%vs all stocks
Payout Ratio
131.58%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
580.67MCNYFY2025 · Dec 31, 2025Revenue
2.45BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
179.09MCNYFY2025 · Dec 31, 2025Gross Profit
2.27BCNYFY2025 · Dec 31, 2025Operating Income
1.37BCNY202.93M · vs all stocks (USD)
Pre-tax Income
1.51BCNYFY2025 · Dec 31, 2025Income Tax Expense
210.59MCNYFY2025 · Dec 31, 2025Net Income
1.30BCNYFY2025 · Dec 31, 2025EBIT
1.52BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.47BCNYFY2025 · Dec 31, 2025Research & Development
359.72MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
228.75MCNYFY2025 · Dec 31, 2025Other Operating Expenses
32.21MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
23.33MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
7.09MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.30BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-10.50MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.39BCNYFY2025 · Dec 31, 2025Free Cash Flow
1.22BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.23BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.30BCNYFY2025 · Dec 31, 2025Other Non-cash Items
44.65MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
53.98MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-9.53MCNYFY2025 · Dec 31, 2025Capital Expenditures
-170.65MCNYFY2025 · Dec 31, 2025Net Acquisitions
-1.40BCNYFY2025 · Dec 31, 2025Purchase of Investments
-13.66BCNYFY2025 · Dec 31, 2025Sale of Investments
14.79BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-439.54MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00CNYFY2025 · Dec 31, 2025Long-term Debt Payments
0.00CNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.52BCNYFY2025 · Dec 31, 2025Other Financing Charges
390.37MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.13BCNYFY2025 · Dec 31, 2025Shares Outstanding
302.59MSharesUpdated Aug 20, 2026Float Shares
129.03MSharesUpdated Aug 20, 2026% Held by Insiders
59.87%vs all stocks
% Held by Institutions
7.53%vs all stocks
Total Cash (MRQ)
3.94BCNY585.82M · vs all stocks (USD)
Total Cash per Share (MRQ)
13.09CNYUpdated Aug 20, 2026Total Debt (MRQ)
8.09MCNY1.20M · vs all stocks (USD)
Current Ratio (MRQ)
7.21xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
26.11CNYUpdated Aug 20, 2026Total Assets
8.91BCNY1.32B · vs all stocks (USD)
Total Current Assets
4.14BCNYFY2025 · Dec 31, 2025Total Liabilities
743.43MCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.76BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
96.93MCNYFY2025 · Dec 31, 2025Total Current Liabilities
646.50MCNYFY2025 · Dec 31, 2025Cash
1.21BCNYFY2025 · Dec 31, 2025Cash Equivalents
21.47MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.23BCNYFY2025 · Dec 31, 2025Other Short-term Investments
2.15BCNYFY2025 · Dec 31, 2025Accounts Receivable
137.89MCNYFY2025 · Dec 31, 2025Inventory
93.21MCNYFY2025 · Dec 31, 2025Accounts Payable
49.69MCNYFY2025 · Dec 31, 2025Short-term Debt
243.11MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.62MCNYFY2025 · Dec 31, 2025Long-term Debt
10.01MCNYFY2025 · Dec 31, 2025Common Stock (Book)
302.59MCNYFY2025 · Dec 31, 2025Retained Earnings
4.16BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.16BCNY1.21B · vs all stocks (USD)
Treasury Stock
399.78MCNYFY2025 · Dec 31, 202552-Week Low
83.36CNYUpdated Aug 20, 202652-Week High
202.88CNYUpdated Aug 20, 202652-Week Change
-48.44%vs all stocks
Beta
0.6160xvs all stocks
50-Day MA
96.42CNYUpdated Aug 20, 2026200-Day MA
124.46CNYUpdated Aug 20, 2026Avg 10-Day Volume
5.42MSharesUpdated Aug 20, 2026Avg 30-Day Volume
6.56MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
3.80CNYUpdated Aug 20, 202612 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 92.5%, higher than 95% of its Medical Instruments & Supplies peers (median 54%)Significant
Gross margin: 0.92Industry median: 0.54Industry P95: 0.78Peers compared: 35.00
Operating margin is 56.5%, higher than 95% of its Medical Instruments & Supplies peers (median 9.3%)Significant
Operating margin: 0.56Industry median: 0.09Industry P95: 0.35Peers compared: 35.00
Profit margin is 47.3%, higher than 95% of its Medical Instruments & Supplies peers (median 7.4%)Significant
Profit margin: 0.47Industry median: 0.07Industry P95: 0.36Peers compared: 35.00
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.85
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $4.24B, above the global median of $1.15BNotable
Market cap (USD): 4,237,933,744.399Global Median: 1,146,734,693.424
Levered free cash flow is $164.8M, above the global median of $16.24MNotable
Levered free cash flow (USD): 164,796,765.43Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Dorman Products Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Qingdao Gon Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Oceaneering International, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Daeduck Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vontier Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Xinquan Automotive Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Griffon Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Atmus Filtration Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Chengdu Xuguang Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Astral Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Goneo Group Co., Ltd.
11 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Dividend Payout With FCF And Equity RatioHigh Retained Earnings With Profitability And EquityFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedRetained Earnings Heavy With Elevated PayoutThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
United States Lime & Minerals Inc.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Cheryong Electric Co., Ltd.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year Revenue And Profit Growth